Equitable Holdings’s SPDR S&P Biotech ETF XBI Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.88M | Sell |
22,699
-700
| -3% | -$58.1K | 0.02% | 592 |
|
|
2025
Q1 | $1.9M | Buy |
23,399
+30
| +0.1% | +$2.43K | 0.02% | 524 |
|
|
2024
Q4 | $2.1M | Buy |
23,369
+1,215
| +5% | +$109K | 0.02% | 472 |
|
|
2024
Q3 | $2.19M | Sell |
22,154
-6,947
| -24% | -$686K | 0.02% | 467 |
|
|
2024
Q2 | $2.7M | Buy |
29,101
+4,819
| +20% | +$447K | 0.03% | 390 |
|
|
2024
Q1 | $2.3M | Buy |
24,282
+4,573
| +23% | +$434K | 0.03% | 411 |
|
|
2023
Q4 | $1.76M | Sell |
19,709
-10,152
| -34% | -$906K | 0.02% | 445 |
|
|
2023
Q3 | $2.18M | Sell |
29,861
-964
| -3% | -$70.4K | 0.03% | 342 |
|
|
2023
Q2 | $2.56M | Sell |
30,825
-3,961
| -11% | -$330K | 0.04% | 296 |
|
|
2023
Q1 | $2.65M | Sell |
34,786
-3,783
| -10% | -$288K | 0.04% | 276 |
|
|
2022
Q4 | $3.2M | Buy |
38,569
+7,758
| +25% | +$644K | 0.06% | 228 |
|
|
2022
Q3 | $2.44M | Buy |
30,811
+3,108
| +11% | +$247K | 0.05% | 230 |
|
|
2022
Q2 | $2.06M | Buy |
27,703
+7,523
| +37% | +$559K | 0.04% | 262 |
|
|
2022
Q1 | $1.81M | Buy |
20,180
+875
| +5% | +$78.7K | 0.03% | 300 |
|
|
2021
Q4 | $2.16M | Sell |
19,305
-7,753
| -29% | -$868K | 0.03% | 267 |
|
|
2021
Q3 | $3.4M | Buy |
27,058
+2,920
| +12% | +$367K | 0.06% | 195 |
|
|
2021
Q2 | $3.27M | Buy |
24,138
+1,549
| +7% | +$210K | 0.06% | 190 |
|
|
2021
Q1 | $3.06M | Sell |
22,589
-18,733
| -45% | -$2.54M | 0.06% | 179 |
|
|
2020
Q4 | $5.82M | Sell |
41,322
-1,333
| -3% | -$188K | 0.13% | 113 |
|
|
2020
Q3 | $4.75M | Buy |
42,655
+3,154
| +8% | +$351K | 0.12% | 115 |
|
|
2020
Q2 | $4.42M | Buy |
39,501
+3,599
| +10% | +$403K | 0.13% | 114 |
|
|
2020
Q1 | $2.78M | Buy |
35,902
+30,996
| +632% | +$2.4M | 0.1% | 130 |
|
|
2019
Q4 | $467K | Buy |
+4,906
| New | +$467K | 0.01% | 414 |
|